Case Study: MN553 Advanced Pharmacology

Unit 9 Case Study

This paper addresses a pharmacological management plan for Mr. NX, including consideration of possible contraindications for CAMs, prescriptive, and non-prescriptive recommendations for management of acute pain and other ongoing disease processes, followed by evaluation strategies.

Pharmacological Management Plan

CAMs Contraindicated with Current Prescriptions

CAMs Contraindicated with Diagnoses

Prescription for Back Pain

Changes in Prescribed Drugs

Follow-Up Evaluations


Strategies for Evaluating Side/Adverse Effects

Strategies for Evaluating Effectiveness

References (examples)

Romm, A. (2011). Overprescribing of antibiotics for children’s upper respiratory infections. Alternative options to consider. Alternative and Complementary Therapies, 17(6), 306–309. Retrieved from

Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M.,…Saag, K. G. (2012). Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.  In U.S. Department of Health and Human Services, Agency for Health Research and Quality, National Guideline Clearinghouse. Retrieved from

You Need a Professional Writer To Work On Your Paper?